Zituvio 25 MG Oral Tablet

RxCUI
2670449
RxNorm name
Zituvio 25 MG Oral Tablet
Display name
Zituvio 25 MG Oral Tablet
Full name
Zituvio 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ZITUVIOSITAGLIPTINZydus Pharmaceuticals (USA) Inc.abfdea45-c0ca-41e3-a510-e89810bc9cfe2025-01-31Warnings, Adverse reactionsExact identifier
rxcui: 2670449
ZITUVIOSITAGLIPTINZydus Lifesciences Limitedb2da9d77-154b-48f7-8793-3f4a24dfafc62025-01-31Warnings, Adverse reactionsExact identifier
rxcui: 2670449

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
abfdea45-c0ca-41e3-a510-e89810bc9cfeZituvio 25 MG Oral Tablet [PSN] · sitagliptin 25 MG Oral Tablet [Zituvio] [SBD] · Zituvio 25 MG Oral Tablet [SY]37These highlights do not include all the information needed to use ZITUVIO safely and effectively. See full prescribing information for ZITUVIO. ZITUVIO® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620250131
b2da9d77-154b-48f7-8793-3f4a24dfafc6Zituvio 25 MG Oral Tablet [PSN] · sitagliptin 25 MG Oral Tablet [Zituvio] [SBD] · Zituvio 25 MG Oral Tablet [SY]36These highlights do not include all the information needed to use ZITUVIO safely and effectively. See full prescribing information for ZITUVIO. ZITUVIO ® (sitagliptin) tablets, for oral use Initial U.S. Approval: 200620250131